Biolase Company Profile (NASDAQ:BIOL)

Analyst Ratings

Consensus Ratings for Biolase (NASDAQ:BIOL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biolase (NASDAQ:BIOL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biolase (NASDAQ:BIOL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016Q216($0.03)$12.90 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2016Q116($0.03)($0.07)$11.90 million$11.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.09)($0.02)$13.90 million$14.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.08)($0.09)$1.50 million$11.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.06)($0.10)$12.30 million$11.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414($0.04)($0.06)$14.90 million$13.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.09)($0.08)$11.70 million$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.08)($0.17)$12.97 million$10.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.05)($0.11)$13.29 million$11.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014Q413($0.04)($0.04)$15.67 million$15.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.05)($0.10)$16.42 million$12.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.04)($0.06)$15.69 million$14.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.01)($0.06)$14.48 million$14.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2013Q4 2012$0.05$18.03 million$19.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biolase (NASDAQ:BIOL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biolase (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biolase (NASDAQ:BIOL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/18/2016Jack W SchulerMajor ShareholderBuy500$0.80$400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Jack W SchulerMajor ShareholderBuy4,100$0.80$3,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Jack W SchulerMajor ShareholderBuy19,080$0.76$14,500.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Jack W SchulerMajor ShareholderBuy67,213$0.78$52,426.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/25/2016Jack W SchulerMajor ShareholderBuy1,400$0.80$1,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2016Jack W SchulerMajor ShareholderBuy6,670$0.78$5,202.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Jack W SchulerMajor ShareholderBuy24,200$0.75$18,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2015Jack W SchulerMajor ShareholderBuy18,350$0.79$14,496.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2015Jack W SchulerMajor ShareholderBuy41,900$0.76$31,844.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Jack W SchulerMajor ShareholderBuy87,200$0.74$64,528.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Jack W SchulerMajor ShareholderBuy127,892$0.73$93,361.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Jack W SchulerMajor ShareholderBuy34,158$0.70$23,910.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Larry N FeinbergMajor ShareholderBuy54,800$0.79$43,292.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Paul N ClarkDirectorBuy134,579$0.75$100,934.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2015David C DreyerCFOBuy5,000$1.20$6,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2015David C DreyerCFOBuy5,000$1.37$6,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015David C DreyerCFOBuy10,000$1.45$14,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jeffrey M NugentCEOBuy40,465$2.39$96,711.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jonathan T Md LordDirectorBuy101,163$2.39$241,779.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Larry N FeinbergMajor ShareholderBuy2,067,979$2.39$4,942,469.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Alexander K ArrowCOOBuy7,812$1.92$14,999.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Frederick D FurryCFOBuy13,020$1.92$24,998.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Jeffrey M NugentCEOBuy52,083$1.92$99,999.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Paul N ClarkDirectorBuy520,833$1.92$999,999.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Larry N FeinbergMajor ShareholderBuy2,270,836$1.92$4,360,005.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Larry N FeinbergMajor ShareholderBuy2,035,033$2.57$5,230,034.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Larry Feinbergmajor shareholderBuy30,798$2.45$75,455.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2013Larry Feinbergmajor shareholderBuy340,000$1.80$612,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013Larry Feinbergmajor shareholderBuy150,400$1.87$281,248.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Frederick D FurryCFOBuy5,075$1.64$8,323.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biolase (NASDAQ:BIOL)
DateHeadline
07/25/16 03:21 PMNew report: Dental equipment market is projected to reach 7.52 billion USD by 2021
07/25/16 07:38 AMBIOLASE : reg; to Host 2016 Second Quarter Financial Results Conference Call on August 1
07/25/16 05:28 AMBIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--Jul. 25, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, August 1, 2016 ...
07/24/16 07:33 AMGlaukos CFO to Retire in 2017
07/23/16 02:47 PMStock Up Nicely This Week: BIOLASE, Inc. (NASDAQ:BIOL) - TGP
07/22/16 02:49 PMAlphatec Holdings Inc versus BIOLASE Inc Head to Head Compare - CML News
07/21/16 02:53 PMInsiders Increasing Positions in: BIOLASE, Inc. (NASDAQ:BIOL) - Press Telegraph
07/21/16 02:53 PMBIOLASE Inc versus Cutera Inc Head to Head Compare - CML News
07/20/16 10:53 AMStock Moving Lower for the Month; Investor Update on BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily
07/19/16 09:01 AMDental Equipment Market Worth 7.52 Billion USD by 2021
07/18/16 02:54 PMBIOLASE Inc versus SeaSpine Holdings Corporation Head to Head Compare - CML News
07/18/16 07:47 AMDental Surgical Equipment Market Rising Due to Increasing Prevalence of Dental Diseases and Growing Aging Population
07/17/16 07:32 AMShares Moving Down on the Week: BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily
07/16/16 08:25 AMShares Experiencing a Downtrend: BIOLASE, Inc. (NASDAQ:BIOL) - TGP
07/13/16 08:18 PMBIOLASE Inc Stock Momentum Hits Weakness - CML News
07/13/16 02:52 PMBiolase, Inc. (BIOL) Updated Price Targets - FTSE News
07/11/16 02:49 PMBIOLASE, Inc. versus Cogentix Medical, Inc. Head to Head Compare - CML News
07/08/16 02:51 PMGlobal Refractive Surgery Devices Market 2016- Alcon, Inc., Avedro, Inc., Belkin Laser Ltd, Biolase, Inc., CV Laser ... - cHollywood News Portal (press release)
07/07/16 10:46 AMBroker Outlook For Biolase, Inc. (BIOL) - Fiscal Standard
07/02/16 10:29 AMCompany Stock Lower on the Week BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily
07/01/16 02:51 PMStock Lower in Session: BIOLASE, Inc. (NASDAQ:BIOL) - Telanagana Press
06/29/16 02:50 PMGlobal Dental Surgical Market Development, Regional Analysis, Share and Forecast to 2027.
06/29/16 11:07 AMGlobal Dental Equipment Market to reach USD 1.8 Billion by 2020
06/28/16 03:01 PMUpcoming Opportunities in Asian Dental Lasers Market by Regions like China, India, Japan, South Korea Analysis and ... - Medgadget.com (blog)
06/27/16 02:29 PMBiolase, Inc. (BIOL) Broker Price Targets For The Coming Week - Fiscal Standard
06/27/16 07:31 AMUpcoming Opportunities in Asian Dental Lasers Market by Regions like China, India, Japan, South Korea Analysis and Forecast to 2019
06/26/16 08:03 AMBiolase Technology Incorporated (NASDAQ:BIOL) Sellers Covered 0.51% of Their Shorts - Engelwood Daily
06/23/16 12:33 PMETF’s with exposure to BIOLASE, Inc. : June 23, 2016 -
06/22/16 02:49 PMNew Broker Ratings For Biolase, Inc. (BIOL) - FTSE News
06/22/16 07:36 AMGlobal dental lasers market by product, by end user - analysis and forecast to 2019 illuminated by new report
06/21/16 02:46 PMDental Lasers North American Market – Opportunities and Forecasts, 2014 – 2022 - Medgadget.com (blog)
06/21/16 07:35 AMRecently Issued Stock Ratings For Biolase, Inc. (BIOL) - Fiscal Standard
06/20/16 09:15 AMThis Weeks Broker Views For Biolase, Inc. (BIOL) - Fiscal Standard
06/17/16 02:46 PMResearch details developments in the Worldwide dental diagnostic & surgical equipment market size, share, trends, growth and forecast 2015 - 2021
06/08/16 02:47 PMBIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/07/16 02:53 PMDental Surgical Equipment Market : Share, Forecast and Demand 2014 – 2020
06/07/16 11:03 AMEuropean Dental Lasers Market by Product, by End-User & by Geography - Analysis and Forecast to 2019
06/06/16 10:13 AMDental Diagnostic & Surgical Equipment Market 2015 and Analysis to 2025
06/03/16 11:25 AMBuy, Sell Or Hold Rating For Biolase, Inc. (BIOL)? - Share Trading News
06/02/16 11:35 AMOphthalmic Lasers - Medical Devices Pipeline Assessment, 2016 - New Study Released - Inc., Bausch & Lomb Incorporated, Belkin Laser Ltd, Biolase, Inc., Carl Zeiss Meditec AG, CV Laser Pty Ltd, IOPtima Ltd., Lensar, Inc., Massachusetts Eye and Ear Infirmary, Nidek Co., Ltd., Princeton University, Rowiak GmbH, Spire Corporation, Stroma ...
06/01/16 05:00 AMBIOLASE to Present at the LD Micro Invitational - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 1, 2016 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 6th annual LD Micro Invitational investor ...
05/30/16 06:13 PMBiolase, Inc. (NASDAQ:BIOL) 1-Year High At $1.95 - Investor Newswire - Biolase, Inc. (NASDAQ:BIOL) 1-Year High At $1.95Investor NewswireBiolase, Inc. (NASDAQ:BIOL), a NCM public traded firm had 34386000 shares floating whereas outstanding shares count is 58257000 resulting in market capitalization of $67.58M. In the last session, Biolase, Inc. (NASDAQ:BIOL) stock settled at $1.16.and more »
05/26/16 10:18 AMBIOLASE, Inc. :BIOL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/12/16 01:58 PMBIOLASE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/12/16 09:52 AMForm 4 BIOLASE, INC For: May 06 Filed by: TALEVICH JAMES R - StreetInsider.com - Form 4 BIOLASE, INC For: May 06 Filed by: TALEVICH JAMES RStreetInsider.comCheck this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. TALEVICH JAMES R. (Last), (First), (Middle). 4 CROMWELL. (Street). IRVINE, CA, 92618. (City) ...and more »
05/09/16 04:13 PMBIOLASE, INC Files SEC form 10-Q, Quarterly Report -
05/09/16 04:02 PMBiolase reports 1Q loss -
05/09/16 03:18 PMBIOLASE Reports 2016 First Quarter Results - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--May 9, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the first quarter ended March 31, 2016. ... This ...
05/09/16 06:07 AMQ1 2016 BIOLASE Inc Earnings Release - After Market Close -
05/04/16 05:20 AMBIOLASE Names New Vice Presidents of Marketing and Human Resources - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--May 4, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that it has appointed veteran medical device executives Michael Roux as its ...

Social

About Biolase

Biolase logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. Combining its laser system products with imaging solutions provides dental professionals capabilities for early diagnosis and minimally invasive treatment. It markets and sells its laser systems in the United States, Canada, the European Union and other countries outside the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOL
  • CUSIP:
Key Metrics:
  • Previous Close: $1.16
  • 50 Day Moving Average: $1.09
  • 200 Day Moving Average: $1.13
  • P/E Ratio: N/A
  • P/E Growth: -0.40
  • Market Cap: $67.58M
  • Beta: 2
Additional Links:
Biolase (NASDAQ:BIOL) Chart for Friday, July, 29, 2016